EC Decision on animal tissue soon, but with concessions
This article was originally published in Clinica
The European Commission is optimistic that the long-awaited Decision on medical devices containing animal tissues will be adopted by the end of the year, possibly in October or November. But some concessions have had to be made which will impact devices containing collagen, gelatine and tallow.
You may also be interested in...
Switzerland’s SIX exchange-listed drug development company, Basilea, is moving two new oncology candidates along its R&D pipeline, supported by strong revenues from two partnered anti-infective products.
Recommendations from the Alliance for Regenerative Medicine aim to improve cross-border healthcare to ensure patients can access advanced therapies.
At the OurCrowd Global Investor Summit in Jerusalem, Israel, on 13 February, Medtech Insight met wound care device company Nanomedic to find out more about its unique electro-spinning technology.